CBD Co. Can't Avoid Stock-Drop Suit, Shareholder Says

Law360 (September 16, 2020, 8:46 PM EDT) -- A shareholder behind a derivative suit against executives of CBD company CV Sciences has urged a California federal judge to keep the suit alive, pointing to another judge's ruling allowing a nearly identical case to go forward.

Shareholder Phillip Berry's suit accuses CV Sciences of promoting one of its flagship products as "patent pending" when the patent had already been rejected by the U.S. Patent and Trademark Office. The suit also claims the company's board refused a request to investigate that accusation.

It is one of several against the company over the same issue, and a judge overseeing one of those...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!